the role of antibody-based therapies in mds treatment
Published 1 year ago • 90 plays • Length 1:41Download video MP4
Download video MP3
Similar videos
-
1:18
the mechanism of action of anti-cd47 antibodies & where these may fit in the mds treatment landscape
-
1:28
cd47 antibodies for the treatment of aml and mds: where is the field moving?
-
2:18
antibody therapies for aml and mds
-
2:43
novel therapies in the future of mds treatment
-
1:48
immune therapy approaches in mds
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
0:52
is there a role for combination therapy in cml?
-
6:50
an overview of the immunotherapy landscape in aml: antibodies, bispecifics, & car-t
-
2:00
the incorporation of immunotherapy into frontline all treatment
-
2:49
the role of the immune system in the pathophysiology of mds
-
1:19
sequencing bispecific antibodies and car-t therapy & the evolving role of bispecifics in myeloma
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
0:47
the role of antiphospholipid antibodies in scd
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
1:25
how the role of transplant in all is evolving with the introduction of novel immunotherapies
-
2:07
emerging targeted treatments for mds
-
3:38
evaluating therapies in mds
-
2:10
using the innate immune system to treat mds & the value of novel immunotherapies